Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
Closing Date
24 Feb 2026, 9:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
COMMANDANT
CH (EC), KOLKATA
PROC OF MED STORES
2026_ARMY_753726_1
EP/D-25/521/2025-26
Limited
Miscellaneous Goods
Buy
7 days
DGLP PROCUREMENT CELL
1 document required · 1 mandatory
₹0
Exempted
21 Feb 2026
21 Feb 2026
24 Feb 2026
21 Feb 2026
24 Feb 2026
21 Feb 2026
21 Feb 2026 - 23 Feb 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Diltiazem 60 mg Tab | 4,300 | No | - | - |
| 2 | Flurbiprofen Sodium Opthalmic sol 0.03% vial of 5 ml | 290 | Amp/Vial | - | - |
| 3 | Metoclopramide 10 mg Tab | 3,200 | No | - | - |
| 4 | Ofloxacin 0.3% Bott of 5 ml | 400 | Bott | - | - |
| 5 | Amoxycillin for oral susp containing Amoxycillin base 125mg per 5ml after reconstitution (bottle of 30ml) | 800 | Bott | - | - |
| 6 | Povidone 5% eye Drop Bott of 5 ml | 50 | Bott | - | - |
| 7 | Tab Bisoprolol 5mg | 4,000 | No | - | - |
| 8 | E/D Hydroxypropyl methyi cellulose with Glycerin and Dextrain 70 ophthalmic solution | 360 | No | - | - |
| 9 | Tab Carbamazepine SR 400 mg | 500 | No | - | - |
| 10 | Asprin (Soluble) 350 mg Tab | 1,300 | No | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.15 MB
BOQ_844219.xls
BOQ • 0.36 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .